Dutch Startup Affix Labs Secures €1 Million to Replace Toxic Insecticides Across Europe

2026-04-24 chemical

Apeldoorn, Friday 24 April 2026
Fuelled by a €1 million investment, Affix Labs is expanding its sustainable insect repellent, offering 12 weeks of non-toxic protection to combat tightening European chemical bans.

Catalysing the Shift to Sustainable Chemtech

On 22 April 2026, Affix Labs Group B.V., a green chemtech startup based in the Netherlands, successfully closed a €1 million funding round [2]. The capital injection was led by the family office VP Capital and the regional development agency Oost NL [1][2][4]. The transaction, which was overseen by legal counsel Jaap van den Broek and Paul Cairo from De Zaak van Advocaten [5], aims to accelerate the European rollout of the company’s proprietary water-based solubility technology [1][2].

Navigating a Tightening Regulatory Landscape

The commercial push for Repeltec aligns with a period of intense regulatory scrutiny across the European Union regarding chemical pesticides [1][2]. Policymakers are increasingly restricting the use of harmful substances, exemplified by Germany’s implementation of a ban on the self-service sale of certain neurotoxic insecticides, which came into effect in 2025 [1][2]. This shifting legal framework has fundamentally altered the market landscape, making the development of safer, sustainable alternatives a pressing commercial necessity [1][6].

Strategic European Expansion and B2B Integration

Armed with new capital, Affix Labs is strategically positioned to scale its operations. The company plans to deepen its distribution networks within its currently authorised markets while concurrently preparing to enter the United Kingdom and Poland [1][2]. [alert! ‘The exact timeline for market entry into the UK and Poland remains unspecified in the current corporate announcements’].

Sources & Ecosystem Partners

Venture funding Green chemtech